Roman Butler Fullerton & Co. Buys 642 Shares of Cigna Corp (NYSE:CI)

Roman Butler Fullerton & Co. raised its stake in Cigna Corp (NYSE:CI) by 7.8% during the second quarter, HoldingsChannel reports. The institutional investor owned 8,842 shares of the health services provider’s stock after acquiring an additional 642 shares during the period. Cigna comprises about 0.9% of Roman Butler Fullerton & Co.’s investment portfolio, making the stock its 24th largest position. Roman Butler Fullerton & Co.’s holdings in Cigna were worth $1,393,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in CI. FMR LLC grew its position in shares of Cigna by 21.6% in the 1st quarter. FMR LLC now owns 12,229,261 shares of the health services provider’s stock valued at $1,966,710,000 after buying an additional 2,171,463 shares during the last quarter. Geode Capital Management LLC grew its position in shares of Cigna by 61.3% in the 4th quarter. Geode Capital Management LLC now owns 4,939,173 shares of the health services provider’s stock valued at $936,405,000 after buying an additional 1,876,556 shares during the last quarter. Dimensional Fund Advisors LP grew its position in shares of Cigna by 82.6% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,539,322 shares of the health services provider’s stock valued at $672,215,000 after buying an additional 1,600,531 shares during the last quarter. Boston Partners grew its position in shares of Cigna by 34.7% in the 1st quarter. Boston Partners now owns 4,895,908 shares of the health services provider’s stock valued at $787,360,000 after buying an additional 1,261,911 shares during the last quarter. Finally, Nordea Investment Management AB grew its position in shares of Cigna by 23.8% in the 1st quarter. Nordea Investment Management AB now owns 3,565,966 shares of the health services provider’s stock valued at $573,487,000 after buying an additional 686,132 shares during the last quarter. Hedge funds and other institutional investors own 88.11% of the company’s stock.

Shares of NYSE:CI traded down $4.46 during midday trading on Friday, reaching $163.10. The company’s stock had a trading volume of 895,056 shares, compared to its average volume of 1,986,662. The firm has a market capitalization of $65.36 billion, a price-to-earnings ratio of 11.47, a price-to-earnings-growth ratio of 0.89 and a beta of 0.71. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.89. The stock has a 50 day moving average of $166.03. Cigna Corp has a fifty-two week low of $141.95 and a fifty-two week high of $226.60.

Cigna (NYSE:CI) last announced its quarterly earnings data on Thursday, August 1st. The health services provider reported $4.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.74 by $0.56. Cigna had a return on equity of 14.23% and a net margin of 4.11%. The company had revenue of $34.38 billion for the quarter, compared to the consensus estimate of $33.27 billion. During the same period in the previous year, the business earned $3.89 EPS. The firm’s revenue was up 198.9% compared to the same quarter last year. As a group, sell-side analysts anticipate that Cigna Corp will post 16.52 EPS for the current year.

A number of research analysts have recently issued reports on the company. Cantor Fitzgerald reissued a “buy” rating and issued a $245.00 price objective on shares of Cigna in a research note on Sunday, April 21st. ValuEngine downgraded Cigna from a “hold” rating to a “sell” rating in a research note on Tuesday, July 23rd. Zacks Investment Research downgraded Cigna from a “buy” rating to a “hold” rating and set a $164.00 price objective on the stock. in a research note on Tuesday, June 11th. Citigroup dropped their price objective on Cigna from $228.00 to $203.00 and set a “buy” rating on the stock in a research note on Monday, June 3rd. Finally, Barclays dropped their price objective on Cigna from $220.00 to $207.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 17th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and fourteen have assigned a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus target price of $217.40.

Cigna Profile

Cigna Corporation, a health service organization, provides insurance and related products and services in the United States and internationally. It operates through Integrated Medical, Health Services, International Markets, and Group Disability and Other segments. The Integrated Medical segment offers medical, pharmacy, dental, behavioral health and vision, health advocacy programs, and other products and services to insured and self-insured clients; Medicare Advantage, Medicare Supplement, and Medicare Part D plans to Medicare-eligible beneficiaries, as well as Medicaid plans; and health insurance coverage to individual customers on and off the public exchanges.

Recommended Story: Earnings Reports

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corp (NYSE:CI).

Institutional Ownership by Quarter for Cigna (NYSE:CI)

Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.